1 recruiting, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Recruiting 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Prostatic Disease: new trials by email Literature Review of Prostatic Disease trials Research Report on Prostatic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer Gedatolisib, Darolutamide - mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male | Phase 1 / Phase 2 | Recruiting | Celcuity Inc | 54 | 2024-01-01 | 2026-04-13 |
| Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA SoracteLite(TM) TPLA for BPH - Male Urogenital Diseases, Genital Diseases, Male | Phase 1 | Unknown | Urological Research Network, LLC | 20 | 2020-11-20 | 2023-01-26 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) P-PSMA-101 CAR-T cells, Rimiducid - Prostatic Neoplasms, Castration-Resistant, Neoplasms by Histologic Type | Phase 1 | Terminated | Poseida Therapeutics, Inc. | 40 | 2020-02-28 | 2025-02-17 |
Prostatic Diseases (3) · Genital Diseases, Male (2) · Male Urogenital Diseases (2) · Prostatic Neoplasms (2) · Prostatic Neoplasms, Castration-Resistant (2) · Carcinoma, Acinar Cell (1) · Carcinoma, Adenoid Cystic (1) · Carcinoma, Mucoepidermoid (1) · Genital Neoplasms, Male (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Prostatic Hyperplasia (1) · Salivary Gland Neoplasms (1) · Urinary Bladder Neck Obstruction (1)
Genital Diseases (3) · Urogenital Diseases (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Adenocarcinoma (1) · Carcinoma (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Head and Neck Neoplasms (1) · Male Urogenital Diseases (1) · Mouth Diseases (1) · Mouth Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplasms, Cystic, Mucinous, and Serous (1)
darolutamide (1) · gedatolisib (1)
Celcuity Inc (1) · Poseida Therapeutics, Inc. (1) · Urological Research Network, LLC (1)
United States (3) · France (1) · Spain (1) · United Kingdom (1)
Fernando Bianco, MD (1) · Nadene Zack, MS (1) · Rajesh Belani, M.D. (1)